POMS Corporation
POMS Corporation, founded 1987, is a Redmond, Washington-based provider of FDA 21 CFR Part 11-compliant manufacturing execution system (MES) software for pharmaceutical, biotech, cell & gene therapy, medical device, and CDMO manufacturers, operating as a subsidiary of Constellation Software's Perseus Operating Group.
- Company typePrivate
- Founded1988
- HeadquartersSterling, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What POMS Corporation does
POMS Corporation is a privately held supplier of manufacturing execution system (MES) software purpose-built for regulated life sciences manufacturers. Founded in 1987/1988 and headquartered in Redmond, Washington, with 51–100 employees, POMS sells the POMS*net* Aquila platform — a cloud-enabled, HTML5-native COTS MES that provides FDA 21 CFR Part 11-compliant electronic batch records, material management, equipment tracking, genealogy, Review by Exception, and IIoT integration. The platform has processed more than 15 million work orders and integrates over 5 million IIoT tags, supports $1 trillion in annual customer revenue, and counts five of the world's ten largest pharmaceutical companies among its customers. POMS operates as a subsidiary of the Perseus Operating Group within Constellation Software Inc. (TSX:CSU), a $3.1 billion vertical-market software conglomerate.
The company sells primarily through direct enterprise field sales targeting pharmaceutical, biotech, cell & gene therapy, medical device, and CDMO manufacturers, complemented by inside sales and a self-serve/SaaS motion for smaller clinical-stage and cell-therapy startups. Revenue is generated via multi-year SaaS subscriptions and on-premises perpetual licenses (with no per-user pricing — all modules are bundled from day one) plus a POMS Professional Services Group that delivers MES Core, Plant, and Global deployment programs. Distribution is reinforced through major industry conference sponsorship (Pharma MES USA/Berlin, ISPE, Phacilitate), Gartner Peer Insights reviews, and named technology partners including SAP and Nymi.
Strategic positioning is anchored on three differentiators: (1) 38+ years of life-sciences-only MES specialization validated by regulators and major pharma buyers; (2) first-mover status on Review by Exception and a touch-screen-ready HTML5 architecture since 2004 web and 2014 cloud releases; and (3) high domain-expert density — average employee tenure of 16.3 years. The most recent product modernization is POMS*net* Aquila 2020.1.0, which added native Nymi biometric authentication, visual dynamic workflows, and a retooled specification manager, with stated forward direction into AI-enabled predictive quality, agentic execution monitoring, and natural-language shop-floor interactions.
POMS Corporation firmographics
Firmographics- Name
- POMS Corporation
- Legal name
- POMS Corporation
- Website
- https://poms.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- POMS Corporation, founded 1987, is a Redmond, Washington-based provider of FDA 21 CFR Part 11-compliant manufacturing execution system (MES) software for pharmaceutical, biotech, cell & gene therapy, medical device, and CDMO manufacturers, operating as a subsidiary of Constellation Software's Perseus Operating Group.
- Ownership category
- akta.pro rank
POMS Corporation industry classification
Industry- Product category
- Pharmaceutical Manufacturing Execution Systems (MES)
- NAICS
- Custom Computer Programming Services (541511), Computer Systems Design Services (541512)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Business Rules & Decision Management Platforms (BRMS/DMN) (HDAEAKAG)
- akta.pro secondary industries
- Clinical Trial Management Systems (CTMS) (HLACAOAD), Document Management Systems (DMS) (HDAEAGAA)
Keywords
Where POMS Corporation is headquartered
LocationHeadquarters
- HQ city
- Sterling
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
POMS Corporation business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Others
Revenue model
- MES Software Licenses and Subscriptions: POMS*net* Aquila MES is sold as a commercial off-the-shelf (COTS) solution with flexible licensing models. The company offers both perpetual software licenses and SaaS subscription options. Licensing simplifies by eliminating per-user counts, making the system easier to scale across sites.
- SaaS (Software as a Service): Cloud-based MES deployment options offered as a subscription. SaaS model eliminates on-site hardware requirements, converts CAPEX to OPEX, provides tax savings as an expense on cost of goods sold, and supports rapid deployment.
- Professional Services and MES Consulting: POMS Professional Services Group provides MES implementation, recipe authoring, validation, testing, and consulting services. Services include MES core deployment strategy, plant rollout, global MES program management, and MES Center of Excellence support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | All-in-One Single Package — All modules included from day one |
| Subscription | Annual | SaaS / Cloud Subscription Option |
| One time/ perpetual license | Multi-year contract | On-Premises Perpetual License |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels8 records
POMS Corporation product offering
Product offeringCore offering
POMS Corporation develops and licenses POMS*net* Aquila, a cloud-enabled, HTML5-native Manufacturing Execution System (MES) purpose-built for pharmaceutical, biotech, cell and gene therapy, and medical device manufacturers. The platform delivers FDA 21 CFR Part 11 compliant electronic batch records, Review by Exception (RBE) for accelerated QA batch release, real-time IIoT integration with plant-floor equipment, and ERP connectivity (including SAP). POMS complements its software with a Professional Services organization offering phased MES implementation (Core, Plant, Global) and validation support.
Product overview
POMS Corporation offers a unified MES platform centered on POMS*net* Aquila, a cloud-enabled, HTML5-based Manufacturing Execution System for life sciences. The core platform includes all modules from day one (not priced separately) and supports electronic batch records, Review by Exception, and FDA 21 CFR Part 11 compliance. Complementary offerings include POMS*net* Falcon EBR Dashboards for real-time analytics, and a Validation Kit for streamlined qualification. Professional Services provide phased deployment options: MES Core (initial implementation), MES Plant (expansion), and MES Global (enterprise-wide standardization) strategies. The company has provided MES solutions since 1988.
Differentiator
Problem solved
Functional benefit
Brands
- POMS*net: The core manufacturing execution system (MES) platform providing electronic batch records, material management, genealogy, equipment tracking, and FDA-compliant paperless manufacturing workflows for life sciences.
- POMS*net* Aquila
- POMS*net* Falcon EBR Dashboards
Products and services
- POMS*net* Aquila MES Cloud-enabled, HTML5-native Manufacturing Execution System for pharmaceutical, biotech, cell and gene therapy, and medical device manufacturers. Unifies ERP and plant-floor systems into a single FDA 21 CFR Part 11 compliant electronic batch record solution with Review by Exception, IIoT integration, and flexible deployment (cloud, on-prem, SaaS). All modules included from day one with no per-user licensing complexity.
- POMS*net* Falcon EBR Dashboards Electronic Batch Record dashboard module providing real-time visibility into manufacturing operations, batch execution, dispense details, order status, exceptions, and equipment data for QA and operations teams in life sciences manufacturing.
- POMS Professional Services Consulting and implementation services for POMS*net* MES deployments including ROI studies, requirements gathering, system configuration, validation support, recipe authoring, testing, and knowledge transfer for pharmaceutical and biotech manufacturers.
- POMS MES Core Deployment Phase 1 MES implementation strategy consulting for initial deployment scope including Material Management (Weigh & Dispense), Equipment Management, or Product Family EBR approaches for life sciences manufacturers.
- POMS MES Plant Deployment Expansion strategy consulting for extending existing MES footprint to rest of plant operations, including recipe authoring, validation kit leverage, and standards development for interfaces in pharmaceutical manufacturing facilities.
- POMS MES Global Program
Quantifiable outcome
- 25–30% reduction in manual errors (Fujirebio Diagnostics case study)
- +6 more outcomes
Companies that use POMS Corporation
Customer profileNamed customers7 records
Segments6 records
Ideal customer profiles5 records
POMS Corporation technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability7 records
Feature10 records
POMS Corporation partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered major, core and minor.
- SAPmajorPOMS provides SAP interfaces enabling integration between POMS*net* MES and SAP ERP systems. Roland Esquivel authored an 'Essential Questions to Ask Your MES Vendor for Successful SAP-to-MES Integration' guide. SAP is one of the primary ERP integrations POMS supports for enterprise customers.
- Constellation Software Inc.coreConstellation Software Inc. (TSX:CSU) is the parent company of POMS Corporation, headquartered in Toronto, Canada. With $3.1 billion revenue and 16,000 employees globally, Constellation acquires, manages, and builds vertical market software businesses. POMS operates within the Perseus Operating Group, a division of Constellation focused on MES software.
- Perseus Operating GroupcorePerseus Operating Group is the operating division within Constellation Software that encompasses POMS Corporation and other MES-related businesses. It is subdivided into several divisions based on market type served. POMS is part of the MES division and shares resources for Finance, Project Management, and IT with the division.
- Science ChannelminorPOMS*net* weighing and dispense module was featured on the Science Channel's 'How It's Made' program, specifically the episode 'How Biologic Medicines are Made,' providing significant brand visibility and credibility.
- Gartner Peer InsightsminorPOMS maintains a presence on Gartner Peer Insights where customers have published reviews endorsing the company's product functionality, consulting partnership, and support quality.
- Turku University of Applied SciencesminorTurku University of Applied Sciences conducted research validating that POMS*net* Aquila was quickly embraced by operators due to its intuitive design at Orion Corporation's manufacturing site.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
POMS Corporation competitors and assessment
Company assessmentDirect peers
- Körber (Werum PAS-X): Körber's Werum PAS-X is widely considered the leading global pharma Manufacturing Execution System, directly competing with POMS*net* Aquila for pharmaceutical, biotech, and cell & gene therapy MES deals. Both target FDA 21 CFR Part 11-compliant electronic batch records and large-pharma multi-site deployments.
- Critical Manufacturing: Critical Manufacturing provides a modern MES specifically targeting high-tech and regulated discrete industries including medical devices and semiconductors with growing life sciences traction, directly competing with POMS*net* for batch-record-driven regulated manufacturers.
Broad incumbents
- Siemens Opcenter Execution: Siemens Opcenter (formerly SIMATIC IT) is a multi-industry MES suite with explicit life sciences packaging and pharma coverage. It competes with POMS at enterprise pharma manufacturers as part of Siemens' broader automation and digital industries portfolio, including Opcenter Execution Pharma.
- Rockwell Automation PharmaSuite: Rockwell's PharmaSuite MES targets pharmaceutical and biotech manufacturers with electronic batch records and ISA-95/ISA-88 alignment, overlapping directly with POMS' core pharma MES offering while leveraging Rockwell's broader automation footprint.
- AVEVA (Schneider Electric) Discrete Event Simulation & MES: AVEVA's MES offerings, integrated with Schneider Electric's industrial software stack, compete for pharma and biotech MES deployments alongside its broader manufacturing operations management portfolio, overlapping with POMS in regulated discrete and batch manufacturing.
Emerging players
- Tulip Interfaces: Tulip is a cloud-native, app-based front-line operations platform increasingly used in life sciences manufacturing for paperless batch records and operator guidance. It overlaps with POMS*net* in pharma MES, particularly in cell & gene therapy and clinical manufacturing use cases.
- Apprentice.io: Apprentice.io provides an AI-native, cloud-based Intelligent Manufacturing Execution System for pharma and biotech, with electronic batch records and Review-by-Exception-style features. It is a venture-backed emerging competitor targeting the same regulated life sciences MES market as POMS.
- MasterControl Manufacturing Excellence: MasterControl's Manufacturing Execution module is part of a broader quality/regulatory platform for life sciences manufacturers. It overlaps with POMS*net* in regulated batch production and electronic batch records, particularly among mid-market pharma and medical device customers.
Regional players
- Elgin Technology Group / PARC Systems (ElgMa): Elgin Technology Group (and affiliated ElgMa platforms) deliver pharma MES and automation solutions primarily across European and emerging markets, comparable to POMS in regulated life sciences and providing a regional-comparable competitor in geographies where POMS is less entrenched.
Others
- ValGenesis: ValGenesis provides validation lifecycle management software for life sciences, adjacent to POMS' offering. While not a direct MES competitor, it competes for IT and validation budgets alongside MES in pharmaceutical manufacturers and is part of the same regulated-life-sciences software ecosystem.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
POMS Corporation social profiles
Digital presencePOMS Corporation compliance and trust
Trust signalCompliance2 records
POMS Corporation financial estimates
Financial estimateRevenue estimate
Valuation estimate
POMS Corporation leadership team
Management profileNumber of profiles
Profiles7 records
POMS Corporation funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
POMS Corporation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about POMS Corporation
What does POMS Corporation do?
POMS Corporation develops and licenses POMS*net* Aquila, a cloud-enabled, HTML5-native Manufacturing Execution System (MES) purpose-built for pharmaceutical, biotech, cell and gene therapy, and medical device manufacturers. The platform delivers FDA 21 CFR Part 11 compliant electronic batch records, Review by Exception (RBE) for accelerated QA batch release, real-time IIoT integration with plant-floor equipment, and ERP connectivity (including SAP). POMS complements its software with a Professional Services organization offering phased MES implementation (Core, Plant, Global) and validation support.
Is POMS Corporation a public or private company?
POMS Corporation is a private company. It is classified as corporate owned and is currently operating.
When was POMS Corporation founded?
POMS Corporation was founded in 1988. It employs 51 to 100 people.
Where is POMS Corporation based?
POMS Corporation is headquartered in Sterling, United States, in the North America region.
How does POMS Corporation make money?
Three revenue lines are on record. MES Software Licenses and Subscriptions are the primary driver. The others are saaS (Software as a Service) and professional Services and MES Consulting.
Who are POMS Corporation's main competitors?
Direct peers on record are Körber (Werum PAS-X) and Critical Manufacturing. Broad incumbents are Siemens Opcenter Execution, Rockwell Automation PharmaSuite and AVEVA (Schneider Electric) Discrete Event Simulation & MES. Emerging players are Tulip Interfaces, Apprentice.io and MasterControl Manufacturing Excellence. Elgin Technology Group / PARC Systems (ElgMa) is listed as a regional player. ValGenesis is listed as an others.
Does POMS Corporation have an API?
No public API is recorded for POMS Corporation.
What industry is POMS Corporation in?
POMS Corporation's product category is Pharmaceutical Manufacturing Execution Systems (MES). Its primary akta.pro industry code is HDAEAKAG, Business Rules & Decision Management Platforms (BRMS/DMN), with a secondary code of HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 541511 and its SIC code is 8731.